IS GALECTIN-3 ANTIBODY A USEFUL MARKER IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA?

REFERENCES

• Bridda , A. ; Padoan , I. ; et al. . Peritoneal mesothelioma: A review . Medscape General Medicine 2007 , 9 , 32 – 33 .
   PubMedGoogle Scholar
• Parkin , D. M. ; Whelan , S. L. ; Ferlay , J. ; Teppo , L. ; Thomas , D. B. Cancer Incidence in Five Continents , Vol VIII; IARC Scientific Publications : Lyon , France , 2002 , p. 781 .
   Google Scholar
• Chedli , A. ; Rethers , L. ; Landreat , A. ; Habanel , B. Epidemiology of cancer in Tunisia: A study of 7959 primary cancers. Archives of Pasteur Institute of Tunis 1976, 4, 317–423.
   Google Scholar
• Ismail-Khan , R. ; Robinson , L. A. ; Williams , C. ; Garrett , C. R. ; Bepler , G. ; Simon , G. R. Malignant pleural mesothelioma: A comprehensive review . Cancer Control 2006 , 13 , 255 – 263 .
   PubMedGoogle Scholar
• Hamzaoui , F. Contribution to the study of pleural mesothelioma (about a retrospective study from 1984 to 1994) . Archives of Pasteur Institute of Tunis 1996 , 5 , 23 – 30 .
   Google Scholar
• Boutin , C. ; Viallat , J. ; Farisse , P. ; Choux , R. Pleurésies asbestosiques bénignes (à propos de trois observations) . Poumon Coeur 1975 , 31 , 111 – 118 .
   PubMedGoogle Scholar
• Nebut , M. ; Delepierre , F. ; Bignon , J. Mesotheliomas. Encyclopédie Médicale et Chirurgicale, 1984, 4.
   Google Scholar
• Peto , J. ; Hodgson , J. T. ; Matthews , F. E. ; Jones , J. R. Continuing increase mesothelioma mortality in Britain . Lancet 1995 , 345 , 535 – 539 .
   PubMed Web of Science ®Google Scholar
• Hodgson , J. T. ; McElcenny , D. M. ; Darnton , A. J. ; Price , M. J. ; Peto , J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 . Br. J. Cancer 2005 , 92 , 587 – 593 .
   PubMed Web of Science ®Google Scholar
• Aziz , T. ; Jilaihawi , A. ; Prakash , D. The management of malignant pleural mesothelioma: Single centre experience in 10 years . Eur. J. Cardiothorac. Surg. 2002 , 22 , 298 – 305 .
   PubMed Web of Science ®Google Scholar
• Porret , J. ; Madelaine , J. ; Galateau-Sallé , F. ; Bergot , E. ; Zalcman , G. Diagnosis and treatment of malignant mesothelioma in 2007 . Rev. Mal. Respir. 2007 , 24 , 157 – 164 .
   Google Scholar
• Brondeau , M. T. ; Clavel , T. ; Falcy , M. ; Jargot , D. ; Reynier , M. ; Schneider , O. Toxicologic note no . 145: Asbestos. INRS 1997 , 167 , 352 – 359 .
   Google Scholar
• Mohr , S. ; Keith , G. ; Rihn , B. Asbestos and malignant pleural mesothelioma: Molecular, cellular and physiopathologic aspects . Bull. Cancer 2005 , 11 , 959 – 968 .
   Google Scholar
• Ozesmi , M. ; Hillerdal , G. ; Svane , B. ; Widstrom , O. Prospective clinical and radiological study of zeolite expose Turkish immigrants in Sweden . Respiration 1990 , 57 , 325 – 328 .
   PubMed Web of Science ®Google Scholar
• Selçuk , Z. T. ; Cöplü , L. ; Emri , S. ; Kalyoncu , A. F. ; Sahin , A. A. ; Baris , Y. I. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey: Analysis of 135 cases . Chest 1992 , 102 , 790 – 796 .
   PubMed Web of Science ®Google Scholar
• Boutin , C. ; Monnet , I. ; Ruffie , P. ; Astoul , P. Malignant mesothelioma: Clinic and therapeutic study . Archives des Maladies Professionnelles 1999 , 60 , 318 – 327 .
   Google Scholar
• Rey , F. ; Viallat , J. R. ; Boutin , C. Environmental mesotheliomas in north-east Corsica . Rev. Mal. Respir. 1993 , 10 , 339 – 345 .
   PubMedGoogle Scholar
• Cugell , D. W. ; Kamp , D. W. Asbestos and the pleura: A review . Chest 2004 , 125 , 1103 – 1117 .
   PubMed Web of Science ®Google Scholar
• Sahin , A. A. ; Cöplü , L. ; et al. . Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients . American Journal of Roentgenology 1993 , 161 , 533 – 537 .
   PubMed Web of Science ®Google Scholar
• Scherpereel , A. ; Astoul , P. ; Baas , P. ; Berghmans , T. ; Clayson , H. ; de Vuyst , P. ; Dienemann , H. ; Galateau-Salle , F. ; Hennequin , C. ; Hillerdal , G. ; Le Péchoux , C. ; Mutti , L. ; Pairon , J. C. ; Stahel , R. ; van Houtte , P. ; van Meerbeek , J. ; Waller , J. ; Weder , W. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma . Eur. Respir. J. 2010 , 35 , 479 – 495 .
   PubMed Web of Science ®Google Scholar
• Robinson , B. W. ; Creaney , J. ; et al. . Mesothelin-family proteins and the diagnosis of mesothelioma . Lancet 2003 , 362 , 1612 – 1616 .
   PubMed Web of Science ®Google Scholar
• Pass , H. I. ; Lott , D. ; et al. . Asbestos exposure, pleural mesothelioma, and serum osteopontin levels . N. Engl. J. Med. 2005 , 353 , 1564 – 1573 .
   PubMed Web of Science ®Google Scholar
• Gueugnon , F. ; Leclercq , S. ; Blanquart , C. ; Sagan , C. ; Cellerin , L. ; Padieu , M. Identification of novel markers for the diagnosis of malignant pleural mesothelioma . Am. J. Pathol. 2011 , 178 , 1033 – 1042 .
   PubMed Web of Science ®Google Scholar
• Zahid , I. ; Sharif , S. ; Routledge , T. ; Scarci , M. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact. Cardiovasc. Thorac. Surg. 2011 , 12 , 254 – 259 .
   PubMedGoogle Scholar
• Margery , J. ; Ruffié , P. Malignant pleural mesothelioma: Challenges and hopes facing an announced epidemy . Rev. Pneumol. Clin. 2007 , 63 , 354 – 364 .
   PubMedGoogle Scholar
• Leong , A. Y. ; Steven , S. W. ; Mukherjee , T. M. Malignant mesothelioma: Cytologic diagnostic with histologic, immune-histochemical and ultrastructural correlation . Seminars in Diagnostic Pathology. 1992 , 9 , 141 – 150 .
   PubMed Web of Science ®Google Scholar
• Hasteh , F. ; Lin , G. Y. ; Weidner , N. ; Michael , C. W. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions . Cancer Cytopathol. 2010 , 25 , 90 – 96 .
   Google Scholar
• Travis , W. D. ; Colhy , T. V. ; Corrin , B. ; Shimosato , Y. ; Brambilla , E. ; in collaboration with pathologists in 14 countries. Histological Typing of Lung and Pleural Tumors, , 3rd Ed.; WHO : Geneva , 1999.
   Google Scholar
• Attanoos , R. L. ; Dojcinov , S. D. ; Webb , R. ; Gibbs , A. R. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms . Histopathology 2000 , 37 , 224 – 231 .
   PubMed Web of Science ®Google Scholar
• Sandeck , H. P. ; Røe , O. D. ; Kjærheim , K. ; Willén , H. ; Larsson , E. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry . Diagn. Pathol. 2010 , 5 , 47 – 48 .
   PubMedGoogle Scholar
• Gueugnon , F. ; Leclercq , S. ; Blanquart , C. ; Sagan , C. Cellerin , L. ; Padieu , M. ; Perigaud , C. ; Scherpereel , A. ; Gregoire , M. Identification of novel markers for the diagnosis of malignant pleural mesothelioma . Am. J. Pathol. 2011 , 178 ( 3 ), 1033 – 1042 .
   PubMed Web of Science ®Google Scholar
• King , J. ; Thatcher , N. ; Pickering , C. ; Haselton , P. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: A systematic review of published reports . Histopathology 2006 , 49 , 561 – 568 .
   PubMed Web of Science ®Google Scholar
• Kato , Y. ; Tsuta , K. ; Seki , K. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma . Mod. Pathol. 2007 , 20 , 215 – 220 .
   PubMed Web of Science ®Google Scholar
• Monaco , S. E. ; Shuai , Y. ; Bansal , M. ; Krarinskas , A. M. ; Dacic , S. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations . Am. J. Clin. Pathol. 2011 , 135 , 619 – 627 .
   PubMed Web of Science ®Google Scholar
• Galateau-Sallé , F. ; Brambilla , E. ; et al. . Immunohistochemical detection of CK5/6 and TTF-1 in the diagnosis of malignant mesothelioma: Experience of the French Mesopath group . Mod. Pathol. 2001 , 14 , 219 – 220 .
   PubMedGoogle Scholar
• Markowska , A. I. ; Liu , F. T. ; Panjwani , N. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response . J. Exp. Med. 2010 , 16 , 1981 – 1993 .
   Google Scholar
• Loganathan , S. ; Kanteti , R. ; Siddiqui , S. ; El-Hashani , E. ; Tretiakova , M. ; et al. . Role of protein kinase C b and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism . J. Carcinog. 2011 , 10 , 4 – 5 .
   PubMedGoogle Scholar
• Kao , S. C. ; Lee , K. ; Armstrong , N. J. ; Clarke , S. ; Vardy , J. ; Van Zandwijk , N. Validation of tissue microarray technology in malignant pleural mesothelioma . Pathology 2011 , 43 , 128 – 132 .
   PubMed Web of Science ®Google Scholar
• van Ruth , S. ; Baas , P. ; Zoetmulder , F. A. Surgical treatment of malignant pleural mesothelioma: A review . Chest 2003 , 123 , 551 – 561 .
   PubMed Web of Science ®Google Scholar
• Bergot , E. ; Moirot , P. ; Lerouge , D. Treatment of malignant pleural mesothelioma in 2009 . Rev. Mal. Respir. 2009 , 1 , 452 – 458 .
   Google Scholar
• Okada , M. ; Mimura , T. ; Ohbayashi , C. ; Sakuma , T. ; Soejima , T. ; Tsubota , N. Radical surgery for malignant pleural mesothelioma: results and prognosis . Interact. Cardiovasc. Thorac. Surg. 2008 , 7 , 102 – 106 .
   PubMedGoogle Scholar
• Borasio , P. ; Berruti , A. ; Billé , A. Malignant pleural mesothelioma: Clinicopathologic and survival characteristics in a consecutive series of 394 patients . Eur. J. Cardiothorac. Surg. 2008 , 33 , 307 – 313 .
   PubMed Web of Science ®Google Scholar